Malin Corporation | MLC - Loan Capital


Malin Corporation reported EUR0 in Loan Capital for its fiscal semester ending in December of 2024.





Loan Capital Change Date
Akebia Therapeutics USD 36.39M 11.85M Mar/2026
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
ALKERMES USD 1.48B 1.2B Mar/2026
Avita Medical AUD 42.24M 1.25M Dec/2024
Dianthus Therapeutics USD 0 0 Dec/2024
Eurofins Scientific SE EUR 3.7B 129.7M Dec/2025
Ionis Pharmaceuticals USD 1.91B 9M Mar/2026
IQVIA Holdings USD 13.99B 105M Mar/2026
Lonza CHF 3.88B 323M Dec/2025
Malin Corporation EUR 0 0 Dec/2024
Moderna USD 603M 7M Mar/2026
Organon & Co USD 8.55B 75M Mar/2026
Ovoca Bio EUR 0 0 Jun/2021
Revvity USD 2.63B 836K Mar/2026
Tectonic Therapeutic USD 43K 57K Dec/2025
Viatris USD 12.41B 67.1M Mar/2026
Xeris Pharmaceuticals USD 221.22M 889K Mar/2026